The Cholinergic Brain in Parkinson's Disease
Jacopo Pasquini1,2, David J Brooks3,4, Nicola Pavese2,4
1Department of Pathophysiology and Transplantation University of Milan Milan Italy.
Movement Disorders Clinical Practice
|October 11, 2021
Summary
Cholinergic system dysfunction in Parkinson's disease (PD) is linked to cognitive decline, gait issues, and REM sleep behavior disorder (RBD). Identifying this "cholinergic phenotype" is key for understanding PD progression.
Area of Science:
- Neuroscience
- Neurobiology
- Neurology
Background:
- The central cholinergic system regulates cognition, locomotion, and sleep.
- Parkinson's disease (PD) involves cholinergic system disruption, impacting various behaviors.
- Pathology in basal forebrain and pontine nuclei correlates with PD symptoms.
Purpose of the Study:
- To review the organization of the central cholinergic system.
- To summarize the clinical correlates of cholinergic dysfunction in PD.
- To identify a "cholinergic phenotype" in PD patients.
Main Methods:
- Review of neuropathological and neuroimaging evidence.
- Analysis of clinical implications of cholinergic dysfunction.
- Synthesis of available evidence on neurotransmitter systems in PD.
Main Results:
- Cholinergic dysfunction is associated with cognitive decline, gait problems, freezing of gait (FOG), falls, REM sleep behavior disorder (RBD), neuropsychiatric issues, and olfactory dysfunction in PD.
- Basal forebrain pathology correlates with cognitive and neuropsychiatric symptoms.
- Pontine and basal forebrain nuclei dysfunction is linked to gait problems, FOG, and falls.
- Olfactory impairment is associated with cholinergic denervation in the hippocampus and amygdala.
Conclusions:
- Cholinergic dysfunction contributes significantly to the clinical manifestations of PD.
- A distinct "cholinergic phenotype" characterized by cognitive decline, falls, and RBD can be identified.
- Understanding cholinergic system involvement is crucial for managing PD symptoms.
Related Concept Videos
01:24Parkinson's Disease: Treatment
444
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
444
01:15Parkinson's Disease: Overview
845
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
845
01:37Neural Regulation
40.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.5K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
979
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
979
01:19Brainstem
3.6K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
3.6K
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.4K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.4K